Ovomet®: Joints

Ovomet. Eggnovo

Clinical studies



People suffering from osteoarthritis with moderate pain, runners and cross-fitters

Recent double blind and placebo controlled studies have demonstrated pain decreases of 28% in 5 days in people practising moderate physical activity, while no benefits were observed in the placebo group. These decreases in pain after 50 days of treatment have reached a 50% in runners and a 60% in athletes who practice crossfit.

In addition to the joint improvement regarding pain, stiffness and function, it has been shown that Ovomet® prevents injuries in tendons and ligaments due to its ability to increase its elasticity compared to a placebo group by 40%.

So ovomet® helps to maintain a regular physical activity and to decrease the risk of injury.

People suffering from osteoarthritis with severe pain

A study performed in an specialised clinic with osteoarthritis diagnosed elderly patients showed that the daily intake of 300mg of Ovomet® during 50 days decreased pain more than 40% and improved joint stiffness a 60%. All the measurements followed standardised and validated methods.

Afterwards a double blind and placebo controlled studied was performed with elderly people with physical limitations. The study showed a pain decrease of 40% and an improvement in tendon elasticity of 48% (in Achilles tendon) compared to the placebo group.

To summarize, the increase in the tendons elasticity allowed the patients to increase their physical activity and to provide them with a greater degree of autonomy and thus significantly improving their quality of life.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies